James Pursley - 01 Apr 2026 Form 4 Insider Report for Hinge Health, Inc. (HNGE)

Role
President
Signature
/s/ James Budge, Attorney-in-Fact
Issuer symbol
HNGE
Transactions as of
01 Apr 2026
Net transactions value
$0
Form type
4
Filing time
01 Apr 2026, 16:24:30 UTC
Previous filing
24 Mar 2026

Sponsored

Quoteable Key Fact

"James Pursley filed Form 4 for Hinge Health, Inc. (HNGE) on 01 Apr 2026."

Quick Takeaways

  • This page summarizes James Pursley's Form 4 filing for Hinge Health, Inc. (HNGE).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Filing timestamp: 01 Apr 2026, 16:24.

What Changed

  • Previous filing in this sequence was filed on 24 Mar 2026.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Pursley James President C/O HINGE HEALTH, INC., 455 MARKET STREET, SUITE 700, SAN FRANCISCO /s/ James Budge, Attorney-in-Fact 01 Apr 2026 0001783108

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HNGE Class A Common Stock Tax liability -831 -0.11% $38.56* 731,273 01 Apr 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units.